Propensity matching was used to assess whether prescribed semaglutide was associated with NAION in patients with type 2 diabetes (T2D) or overweight/obesity, in each case accounting for covarying factors (sex, age, systemic hypertension, T2D, obstructive sleep apnoea, obesity, hyperlipidemia, and coronary artery disease) and contraindications for use of semaglutide
and I have been going to Synergy for a year now
Limited clinical evidence in this population means prescribing decisions require careful individualised assessment, ideally involving both gastroenterology and weight management specialists to balance potential benefits against risks
The specific biological mechanisms for the relationships identified between C3DC, C4, C10:1, and C10:2 with breast cancer are still uncertain
Journal of clinical medicine, 12(1), 145
Can Liposomal Glutathione help with detoxification